Allied Biotech Corporation (TPEX:1780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
-0.25 (-0.81%)
Apr 29, 2026, 1:07 PM CST
82.25%
Market Cap 2.99B
Revenue (ttm) 849.51M
Net Income (ttm) 129.46M
Shares Out 96.24M
EPS (ttm) 1.34
PE Ratio 23.17
Forward PE n/a
Dividend 1.25 (4.04%)
Ex-Dividend Date Jul 17, 2025
Volume 61,288
Average Volume 247,431
Open 31.05
Previous Close 31.05
Day's Range 30.50 - 31.10
52-Week Range 16.60 - 35.50
Beta -0.08
RSI 60.44
Earnings Date May 4, 2026

About Allied Biotech

Allied Biotech Corporation engages in the manufacture and sale of carotenoids worldwide. The company’s products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. It also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage ap... [Read more]

Sector Healthcare
Founded 2001
Employees 40
Stock Exchange Taipei Exchange
Ticker Symbol 1780
Full Company Profile

Financial Performance

In 2025, Allied Biotech's revenue was 849.51 million, an increase of 5.28% compared to the previous year's 806.92 million. Earnings were 129.46 million, an increase of 28.25%.

Financial Statements

News

There is no news available yet.